Pharmaceutical ingredients

Our company has been working for a lot of projects involving excipients and pharmaceutical active ingredients. We are proud to count with the confidence of some of the bigest and most reputed API manufacturers of the world.

We provide services of method development and validation, including stress testing and photostability when required, as well as ICH stability studies. Pharmaceutical ingredient manufacturers are facing a lot of analytical challenges due to the new requiremets regarding residual solvents, genotoxic impurities and elemental impurities. In addition microbiological testing is nowadays required not only for sterile ingredients but for non-sterile ones.

 

CMC

Chemistry, Manufacturing & Control analytical services are conducted under GMP compliance. During development phases may be executed under GLP if it is a Client's requirement.

ASK US A QUOTATION

 

Working with biologic drugs represents a huge analytical effort to deeply understand the whole molecule characteristics. Different methods and technologies are needed to get the analytical fingerprint. An extensive analytical characterization based on an ortogonal approach is a key element for the project success. We can afford complex characterization projects of innovative biologics or biosimilars comparison.

We have a wide experience in performing analytical tests for APIsexcipientsintermediate productsfinished productspackaging materials and process environment samples. The most suitable method is used, according to customer specifications or the relevant Pharmacopoeias description (EP, USP, BP, JP). If non-compendial methods should be used, we perform the method development and validation from scratch or the method transfer from the manufacturer.

We have a comprehensive knowledge in the development and validation of analytical proprietary and non-proprietary methods for excipients, APIs, intermediate products and finished products, according to the ICH Q2 (R1) in line with Q6A and Q6B. Our methods are ready for transfer to contract-giver, in compliance with EU-GMP chapter 6, performing a comparative test, a co-validation in two sites or a revalidation.

We provide full service of ICH and on-going stability programs for third parties. The services, at client's choice, can include: method transfer, method improvement, analytical standards management, storage at different conditions, scheduling of analytical timepoints, full analysis and out-of-trend (OOT) and out-of-specification (OOS) management. These tasks are always performed according to procedures agreed with the client.

We provide microbiological testing for sterile and non-sterile APIs and drug products. A fully-equiped laboratory is available including a cleanroom with airlock tecnology and HEPA filters for the most sensitive operations. A 4 gloves isolator ISOFLEX-S is equiped with a Steritest pump and a H2O2 generator. The main advantage of using isolation technology for sterility testing is to assure that non-false positive results are obtained.

We provide services of Elemental Impurities Analysis by ICP-MS according to ICH Q3D and European Pharmacopoeia and USP General Chapters <232>, <233> and <2232> for drug substances, excipients and drug products. We also assess on the extension of the risk analysis required in order to minimize the analytical workload.

Revised monographs in the European Pharmacopoeia on heparin sodium (0333) and heparin calcium (0332) are in force from January 1st, 2015. These monographs include chromogenic assays of anti-factor IIa and anti-factor Xa activities. USP monograph for Heparin sodium had been previously updated.

We have implemented and validated these challenging assays according to USP monograph and are ready to be used for drug product and drug substance. However, personalized method adjustments are necessary in a case by case basis.

Cleaning validation is a relevant GMP activity to prevent contamination of biopharmaceutical products by ensuring that the processing equipment is suitable for following manufacturing processes. Potential contaminants include residues of the active pharmaceutical ingredients or their related substances, and residues from the products used during the cleaning process such as solvents or detergents. This is particullary important for highly-sensitizing compounds such as antibiotics, hormones and cytotoxics and in the case of parenteral drug products.

Bioanalysis

Chemistry, Manufacturing & Control analytical services are conducted under GMP compliance. During development phases may be executed under GLP if it is a Client's requirement.

ASK US A QUOTATION

 

We offer you our experience in studies of Percutaneous Absorption for topical semisolid drug products using vertical diffusion cells (o Franz cells) according to Chapter <725> of the Pharmacopeial Forum. Both In Vitro Release Test and In Vitro Permeation Test are offered: